Search results
Results from the WOW.Com Content Network
Officials of the Marine Hospital Service in New York decided to open a research laboratory to study the link between microscopic organisms and infectious diseases. Joseph J. Kinyoun, a medical officer with the Marine Hospital Service, was selected to create this laboratory, which he called a "laboratory of hygiene." [4]
The NIAID-funded Influenza Genome Sequencing Project is a collaborative effort designed to increase the genome knowledge base of influenza and help researchers understand how flu viruses evolve, spread and cause disease. [6] 1948 $4,512.9 www.niaid.nih.gov: National Institute of Dental and Craniofacial Research: NIDCR
The Division of Acquired Immunodeficiency Syndrome (DAIDS) is a division of the National Institute of Allergy and Infectious Diseases, which is part of the National Institutes of Health. It was formed in 1986 as a part of the initiative to address the national research needs created by the advent and spread of the HIV/AIDS epidemic. [1]
The Vaccine Research Center (VRC), is an intramural division of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), US Department of Health and Human Services (HHS). The mission of the VRC is to discover and develop both vaccines and antibody-based products that target infectious ...
This category is for clinical trials sponsored by the National Institute of Allergy and Infectious Diseases (NIAID). Pages in category "Clinical trials sponsored by NIAID" The following 3 pages are in this category, out of 3 total.
The Medical Scientist Training Programs (MSTPs) are dual-degree training programs that streamline the education towards both clinical (typically MD) and research doctoral degrees. [1] MSTPs are offered by some United States medical schools, who are awarded financial support from the National Institute of General Medical Sciences , a branch of ...
The Bioinformatics Resource Centers (BRCs) are a group of five Internet-based research centers established in 2004 and funded by NIAID (the National Institute of Allergy and Infectious Diseases.) [1] The BRCs were formed in response to the threats posed by emerging and re-emerging pathogens, particularly Centers for Disease Control and Prevention (CDC) Category A, B, and C pathogens, [2] and ...
cAd3-ZEBOV (also known as the NIAID/GSK Ebola vaccine or cAd3-EBO Z) was an experimental vaccine for two ebolaviruses, Ebola virus and Sudan virus, developed by scientists at GlaxoSmithKline (GSK) and tested by National Institute of Allergy and Infectious Disease (NIAID). [1]